Received Nov 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4D255 | IM / RA |
Patient 20yr old female received FluLaval (6mo+) on 9/23/2025 which is a state issued vaccine. Patient should have received FluBlok on 9/23/2025 which is a private issued vaccine since she is 18+. The order was originally for FluLaval, which was administered, however should have been FluBlok. At this time, I am not aware of any adverse effects the patient might have experienced.